pharmacoeconomic guidelines in south africa
TRANSCRIPT
PE GUIDELINES PANEL DISCUSSION
TCD OUTCOMES RESEARCH © 2016 | 1
PE GUIDELINES PANEL DISCUSSION
TCD OUTCOMES RESEARCH © 2016 | 2
FRAMEWORK
PE GUIDELINES PANEL DISCUSSION
TCD OUTCOMES RESEARCH © 2016 | 3
THE QUESTION
PE GUIDELINES PANEL DISCUSSION
TCD OUTCOMES RESEARCH © 2016 | 4
THE “SO WHAT?” FACTOR
What are my benefits? What are my risks?
How can/will it enhance my strategic objectives?
PE GUIDELINES PANEL DISCUSSION
TCD OUTCOMES RESEARCH © 2016 | 5
THE “SO WHAT?” FACTOR
What are my benefits?
• First mover advantage
• Image and relationships
• Enhancing my Public Sector strategy
• In case of a positive outcome
• Learning as a competitive advantage: towards compulsory submissions
• Will it lead to increased sales?
PE GUIDELINES PANEL DISCUSSION
TCD OUTCOMES RESEARCH © 2016 | 6
THE “SO WHAT?” FACTOR
• What are my risks?
• Expensive investment: opportunity cost
• Is there a gold medal at the end of the race?
• The looser takes it all?
• Only three outcomes from the PC
• Two Acts not talking to each other
• No guaranteed reimbursement
• Voluntary?
• ROI
PE GUIDELINES PANEL DISCUSSION
TCD OUTCOMES RESEARCH © 2016 | 7
THE “SO WHAT?” FACTOR
How can/will it enhance my strategic objectives?
• First time right
• Part of a strategy to enhance access and reimbursement
• Value story
• Funder engagement
• Other stakeholder engagement
PE GUIDELINES PANEL DISCUSSION
TCD OUTCOMES RESEARCH © 2016 | 8
www.tcd-global.com
Dynamic Solutions to Dynamic QuestionsTM